Author

K. C. Anderson

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Biochemistry· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 2 Approach:genetic perturbation / CRISPR· 2 Organism:human· 2 Approach:statistical model· 2 Assay:bulk RNA-seq· 1 Research Focus:chromatin & epigenetic regulation· 1 Research Focus:clustering· 1 Approach:deep learning· 1

Frequent Co-Authors

M. Fulciniti· 2 shared M. K. Samur· 2 shared T. Hideshima· 2 shared A. Aktas-Samur· 1 shared A. Fullam· 1 shared A. Gulla· 1 shared A. Neri· 1 shared B. Rodriguez-Martin· 1 shared

Activity by Year

2018-2021 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

M. Fulciniti

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Long Noncoding RNA RROL Provides Chromatin Scaffold for MYC-WDR82 Interaction to Impact Lipid Metabolism and Tumor Cell Growth in Multiple Myeloma

E. Morelli, M. Fulciniti, M. K. Samur, C. F. Ribeiro, L. Wert-Lamas, J. E. Henninger, A. Gulla, A. Aktas-Samur, K. Todoerti, S. Talluri, W. D. Park, C. Federico, F. Scionti, N. Amodio, G. Bianchi, , N. C. Munshi

This study identifies RROL as a therapeutically actionable lncRNA in multiple myeloma that supports tumor growth through chromatin scaffolding of MYC-WDR82 interaction.

bioRxiv · Dec 8, 2021 · PreprintCancer Biology

Development of PRPK Directed Phthalimides

H.-S. Seo, T. Mizutani, T. Hideshima, N. E. Vangos, T. Zhang, K. C. Anderson, N. S. Gray, S. Dhe-Paganon

This paper develops PRPK-directed phthalimides based on pomalidomide, identifies a potent and selective PRPK binder, and highlights distinct binding mechanisms compared to cereblon.

bioRxiv · Nov 30, 2021 · PreprintBiochemistry

Genomic landscape and chronological reconstruction of driver events in multiple myeloma

F. Maura, N. Bolli, N. Angelopoulos, K. J. Dawson, D. Leongamornlert, I. Martincorena, T. J. Mitchell, A. Fullam, S. Gonzalez, R. Szalat, B. Rodriguez-Martin, M. K. Samur, D. Glodzik, M. Roncador, M. Fulciniti, , P. J. Campbell

This study reconstructs the genomic evolution of multiple myeloma by analyzing 67 genomes from 30 patients and public datasets, identifying 7 subgroups defined by distinct driver mutations and chronological patterns of genomic events.

bioRxiv · Aug 12, 2018Cancer Biology